On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s disease had been chasing for decades: compelling evidence that a gene-targeting therapy could slow the relentless…
Continue Reading
News Source: www.nature.com

Leave a Reply